270 related articles for article (PubMed ID: 29413276)
21. Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases.
Glitza IC; Guha-Thakurta N; D'Souza NM; Amaria RN; McGovern SL; Rao G; Li J
Melanoma Res; 2017 Dec; 27(6):580-584. PubMed ID: 28817446
[TBL] [Abstract][Full Text] [Related]
22. Results of excision of cerebral radionecrosis: experience in patients treated with radiation therapy for nasopharyngeal carcinoma.
Wong ST; Loo KT; Yam KY; Hung WM; Fok KF; Yuen SC; Fong D
J Neurosurg; 2010 Aug; 113(2):293-300. PubMed ID: 20151776
[TBL] [Abstract][Full Text] [Related]
23. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
[TBL] [Abstract][Full Text] [Related]
24. Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues.
Zhuang H; Shi S; Yuan Z; Chang JY
Mol Cancer; 2019 Feb; 18(1):21. PubMed ID: 30732625
[TBL] [Abstract][Full Text] [Related]
25. Bevacizumab as a treatment option for radiation-induced cerebral necrosis.
Matuschek C; Bölke E; Nawatny J; Hoffmann TK; Peiper M; Orth K; Gerber PA; Rusnak E; Lammering G; Budach W
Strahlenther Onkol; 2011 Feb; 187(2):135-9. PubMed ID: 21336713
[TBL] [Abstract][Full Text] [Related]
26. Surgical techniques in radiation induced temporal lobe necrosis in nasopharyngeal carcinoma patients.
Alfotih GT; Zheng MG; Cai WQ; Xu XK; Hu Z; Li FC
Neurol Neurochir Pol; 2016; 50(3):172-9. PubMed ID: 27154443
[TBL] [Abstract][Full Text] [Related]
27. Bevacizumab Combined with Corticosteroids Does Not Improve the Clinical Outcome of Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
Li H; Rong X; Hu W; Yang Y; Lei M; Wen W; Yue Z; Huang X; Chua MLK; Li Y; Cai J; He L; Pan D; Cheng J; Pi Y; Xue R; Xu Y; Tang Y
Front Oncol; 2021; 11():746941. PubMed ID: 34650930
[TBL] [Abstract][Full Text] [Related]
28. Bevacizumab is more effective in nasopharyngeal carcinoma patients with lower maximum radiation dose to the temporal lobe.
Garsa A; Ho JC; Hu C; Chang EL
Chin Clin Oncol; 2019 Oct; 8(S1):S20. PubMed ID: 31280572
[No Abstract] [Full Text] [Related]
29. Bevacizumab reverses cerebral radiation necrosis.
Wong ET; Huberman M; Lu XQ; Mahadevan A
J Clin Oncol; 2008 Dec; 26(34):5649-50. PubMed ID: 18981459
[No Abstract] [Full Text] [Related]
30. Machine-learning based MRI radiomics models for early detection of radiation-induced brain injury in nasopharyngeal carcinoma.
Zhang B; Lian Z; Zhong L; Zhang X; Dong Y; Chen Q; Zhang L; Mo X; Huang W; Yang W; Zhang S
BMC Cancer; 2020 Jun; 20(1):502. PubMed ID: 32487085
[TBL] [Abstract][Full Text] [Related]
31. Statin treatment may lower the risk of postradiation epilepsy in patients with nasopharyngeal carcinoma.
Rong X; Yin J; Wang H; Zhang X; Peng Y
Epilepsia; 2017 Dec; 58(12):2172-2177. PubMed ID: 29034463
[TBL] [Abstract][Full Text] [Related]
32. Bevacizumab for the Treatment of Gammaknife Radiosurgery-Induced Brain Radiation Necrosis.
Ma Y; Zheng C; Feng Y; Xu Q
J Craniofac Surg; 2017 Sep; 28(6):e569-e571. PubMed ID: 28749838
[TBL] [Abstract][Full Text] [Related]
33. Radiation necrosis of the pons after radiotherapy for nasopharyngeal carcinoma: diagnosis and treatment.
DeSalvo MN
J Radiol Case Rep; 2012 Jul; 6(7):9-16. PubMed ID: 23365707
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.
Gecici NN; Gurses ME; Kaye B; Jimenez NLF; Berke C; Gökalp E; Lu VM; Ivan ME; Komotar RJ; Shah AH
J Neurooncol; 2024 May; 168(1):1-11. PubMed ID: 38619777
[TBL] [Abstract][Full Text] [Related]
35. Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma.
Chen Z; Xu XH
Saudi Med J; 2015 Jun; 36(6):659-64. PubMed ID: 25987106
[TBL] [Abstract][Full Text] [Related]
36. Radiation-induced brain structural and functional abnormalities in presymptomatic phase and outcome prediction.
Ding Z; Zhang H; Lv XF; Xie F; Liu L; Qiu S; Li L; Shen D
Hum Brain Mapp; 2018 Jan; 39(1):407-427. PubMed ID: 29058342
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral and peritumoral post-irradiation changes, but not viable tumor tissue, may respond to bevacizumab in previously irradiated meningiomas.
Furuse M; Nonoguchi N; Kawabata S; Miyata T; Toho T; Kuroiwa T; Miyatake S
Radiat Oncol; 2015 Jul; 10():156. PubMed ID: 26223253
[TBL] [Abstract][Full Text] [Related]
38. Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.
McDonald CR; Delfanti RL; Krishnan AP; Leyden KM; Hattangadi-Gluth JA; Seibert TM; Karunamuni R; Elbe P; Kuperman JM; Bartsch H; Piccioni DE; White NS; Dale AM; Farid N
Neuro Oncol; 2016 Nov; 18(11):1579-1590. PubMed ID: 27106406
[TBL] [Abstract][Full Text] [Related]
39. VEGFR-TKI treatment for radiation-induced brain injury after gamma knife radiosurgery for brain metastases from renal cell carcinomas.
Noda R; Akabane A; Kawashima M; Uchino K; Tsunoda S; Segawa M; Inoue T
Jpn J Clin Oncol; 2023 Mar; 53(4):355-364. PubMed ID: 36579769
[TBL] [Abstract][Full Text] [Related]
40. Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy.
Lin Z; Yang Z; He B; Wang D; Gao X; Tam SY; Wu VWC
PLoS One; 2018; 13(7):e0200310. PubMed ID: 29985952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
